The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trialSimon Parlow, Christopher Glover, Juan Russo et al.|European Heart Journal Acute Cardiovascular Care|2021Cited by 41
Plasminogen Activator Inhibitor-1–Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC PhenotypeRichard G. Jung, Benjamin Hibbert, Anne‐Claire Duchez et al.|JACC Basic to Translational Science|2022Cited by 11
Impact of intracoronary assessments on revascularization decisions: A contemporary evaluationTaylor Gillmore, Benjamin Hibbert, Richard G. Jung et al.|Catheterization and Cardiovascular Interventions|2022Cited by 4
Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisationRichard G. Jung, Benjamin Hibbert, Omar Abdel‐Razek et al.|Open Heart|2022Cited by 1
TCT-103 Impact of Preexisting and New Atrial Fibrillation on Major Adverse Cardiac Events After Coronary RevascularizationOmar Abdel‐Razek, Benjamin Hibbert, Richard Jung et al.|Journal of the American College of Cardiology|2022Cited by 0